Wearable Injectors Market by Technology, Type, Application and End User - Global Industry Analysis and Forecast to 2027
Published On : August 2017 Pages : 110 Category: Medical Devices Report Code : HC06164
Industry Trend Analysis
The global wearable injectors market is expected to be around $14 billion by 2027. Some of the key factors driving the market growth are, ease of administering drugs in home care settings, increasing need of advanced drug delivery systems that can be used with minimal expertise and increasing demand for better patient care. Also, the advantages of wearable injectors over traditional modes of drug delivery requiring subcutaneous injections are also expected to fuel their adoption during the forecast period. Moreover, growing applications of biologics will also favorably contribute the growth of wearable injectors market as wearable injectors are appropriate mode of drug delivery for biologics. However, availability of alternative drug delivery methods can hinder the market growth during the forecast period.
Technology Outlook and Trend Analysis
Developments in electronic wearable injectors have offered new opportunities for the drug delivery industry in recent years as these are easy to use and do not require advanced patient-training. Mechanical injectors are self-administration devices which are used by the patients for manually administering the drugs. These devices either come pre-loaded with drugs or can be loaded at the time of administration.
Type Outlook and Trend Analysis
Based on the type of wearable injectors, the market is segmented into off-body worn belt injectors, body-worn patch injectors and other injectors. The growth of body worn patch injectors segment is expected to be limited by factors such as adhesive fitting issues, issues related to sensitivity and irritation of the skin and painful removal of the patches. With technological advancements in wearable injectors, their adoption is expected to increase significantly over the forecast period prompting the development of improved delivery mechanisms in coming years.
Application Outlook and Trend Analysis
Based on the applications of wearable injectors, the market is segmented into blood disorder, cancer, infectious diseases, autoimmune disorders, cardiovascular disorders and other applications. Cancer segment is expected to be the largest segment during the forecast period in terms of market share owing to increasing incidence of cancer around the world.
End User Outlook and Trend Analysis
In 2017, the home care segment dominated the end user market for wearable injectors due to the convenience offered by wearable injectors to be used in home care setting with minimal assistance. Use of wearable injectors in home care setting reduces patient’s visits to the hospital and helps in reducing the associated cost. This largely improves the quality of life of patients who need to receive frequent drug doses. Also, increasing prevalence of geriatric population around the world will also considerably contribute to the growth of home care segment during the forecast period.
Regional Outlook and Trend Analysis
North America dominated the global wearable injectors market in 2017 owing to availability of advanced healthcare infrastructure in the region and increasing demand for self-administration drug delivery devices. Also, increasing prevalence of lifestyle disorders chronic diseases is also expected to favorably contribute to the market growth during the forecast period. Asia-Pacific wearable injectors market is expected to witness favorable growth during the forecast period owing to the presence of unmet medical needs in the region and increasing focus on improving healthcare infrastructure.
Competitive Analysis
The key players operating in the global wearable injectors market emphasize on strategic collaborations to strengthen their product portfolio and ensure a larger share of the market. For instance, in February 2017, Unilife Corporation collaborated with Amgen Inc. for injectable drug delivery systems. In this collaboration, Unilife Corporation has granted Amgen Inc., the rights for Unilife’s prefilled, customizable wearable injectors. Some of the key players operating in this market are, Amgen Inc., Enable Injections, Inc., Insulet Corporation, West Pharmaceutical Services, Inc., Becton, Dickinson and Company, Ypsomed AG, Unilife Corporation and Sensile Medical AG.
Market Opportunities
With significant increase in prevalence of geriatric population globally, the demand for wearable injectors is expected to rapidly increase in coming years. As the preference for home health care by the patient community increases, the demand for favorable medical devices is also expected to escalate during the forecast period. With presence of highly unmet medical needs in emerging economies such as China, India and Brazil, the companies operating in the global wearable injectors have lucrative growth opportunities in such evolving markets during the forecast period.
Wearable Injectors Market Segmentation:
By Technology:
- Mechanical Injectors
- Electronic Injectors
- Other Technologies
By Type:
- Off-Body Worn Belt Injectors
- Body-Worn Patch Injectors
- Other Injector Types
By Application:
- Blood Disorders
- Infectious Diseases
- Cancer
- Cardiovascular Diseases
- Autoimmune Disorders
- Other Applications
By End User:
- Lab and Diagnostics
- Hospital Care
- Home Care
- Other End Users
By Region:
- North America
- U.S
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- Australia
- India
- South Korea
- Rest of Asia-Pacific
- Rest of the World
- Brazil
- South Africa
- Saudi Arabia
- Turkey
- United Arab Emirates
- Others
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2022 to 2027?
- What will be the industry market growth from 2022 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
- Wearable Injectors Market, By Technology, Estimates and Forecast, 2017-2027 ($Million)
- Mechanical Injectors
- Electronic Injectors
- Others Technologies
- Wearable Injectors Market, By Type, Estimates and Forecast, 2017-2027 ($Million)
- Body-Worn Patch Injectors
- Off-Body Worn Belt Injectors
- Other Injector Types
- Wearable Injectors Market, By Application, Estimates and Forecast, 2017-2027 ($Million)
- Blood Disorders
- Infectious Diseases
- Cancer
- Cardiovascular Diseases
- Autoimmune Disorders
- Other Applications
- Wearable Injectors Market, By End User, Estimates and Forecast, 2017-2027 ($Million)
- Lab and Diagnostics
- Hospital Care
- Home Care
- Other End Users
- Wearable Injectors Market, By Region, Estimates and Forecast, 2017-2027 ($Million)
- North America
- North America Wearable Injectors Market, By Country
- North America Wearable Injectors Market, By Technology
- North America Wearable Injectors Market, By Type
- North America Wearable Injectors Market, By Application
- North America Wearable Injectors Market, By End User
- U.S. Wearable Injectors Market, By Technology
- U.S. Wearable Injectors Market, By Type
- U.S. Wearable Injectors Market, By Application
- U.S. Wearable Injectors Market, By End User
- Canada Wearable Injectors Market, By Technology
- Canada Wearable Injectors Market, By Type
- Canada Wearable Injectors Market, By Application
- Canada Wearable Injectors Market, By End User
- Mexico Wearable Injectors Market, By Technology
- Mexico Wearable Injectors Market, By Type
- Mexico Wearable Injectors Market, By Application
- Mexico Wearable Injectors Market, By End User
-
- Europe
- Europe Wearable Injectors Market, By Country
- Europe Wearable Injectors Market, By Technology
- Europe Wearable Injectors Market, By Type
- Europe Wearable Injectors Market, By Application
- Europe Wearable Injectors Market, By End User
- Germany Wearable Injectors Market, By Technology
- Germany Wearable Injectors Market, By Type
- Germany Wearable Injectors Market, By Application
- Germany Wearable Injectors Market, By End User
- France Wearable Injectors Market, By Technology
- France Wearable Injectors Market, By Type
- France Wearable Injectors Market, By Application
- France Wearable Injectors Market, By End User
- UK Wearable Injectors Market, By Technology
- UK Wearable Injectors Market, By Type
- UK Wearable Injectors Market, By Application
- UK Wearable Injectors Market, By End User
- Italy Wearable Injectors Market, By Technology
- Italy Wearable Injectors Market, By Type
- Italy Wearable Injectors Market, By Application
- Italy Wearable Injectors Market, By End User
- Spain Wearable Injectors Market, By Technology
- Spain Wearable Injectors Market, By Type
- Rest of Europe Wearable Injectors Market, By Technology
- Rest of Europe Wearable Injectors Market, By Type
- Rest of Europe Wearable Injectors Market, By Application
- Rest of Europe Wearable Injectors Market, By End User
-
- Asia-Pacific
- Asia-Pacific Wearable Injectors Market, By Country
- Asia-Pacific Wearable Injectors Market, By Technology
- Asia-Pacific Wearable Injectors Market, By Type
- Asia-Pacific Wearable Injectors Market, By Application
- Asia-Pacific Wearable Injectors Market, By End User
- Japan Wearable Injectors Market, By Technology
- Japan Wearable Injectors Market, By Type
- Japan Wearable Injectors Market, By Application
- Japan Wearable Injectors Market, By End User
- Australia Wearable Injectors Market, By Technology
- Australia Wearable Injectors Market, By Type
- Australia Wearable Injectors Market, By Application
- Australia Wearable Injectors Market, By End User
- India Wearable Injectors Market, By Technology
- India Wearable Injectors Market, By Type
- India Wearable Injectors Market, By Application
- India Wearable Injectors Market, By End User
- South Korea Wearable Injectors Market, By Technology
- South Korea Wearable Injectors Market, By Type
- South Korea Wearable Injectors Market, By Application
- South Korea Wearable Injectors Market, By End User
- Rest of Asia-Pacific Wearable Injectors Market, By Technology
- Rest of Asia-Pacific Wearable Injectors Market, By Type
- Rest of Asia-Pacific Wearable Injectors Market, By Application
- Rest of Asia-Pacific Wearable Injectors Market, By End User
- Asia-Pacific
-
- Rest of the World
- Rest of the World Wearable Injectors Market, By Country
- Rest of the World Wearable Injectors Market, By Technology
- Rest of the World Wearable Injectors Market, By Type
- Rest of the World Wearable Injectors Market, By Application
- Rest of the World Wearable Injectors Market, By End User
- Brazil Wearable Injectors Market, By Technology
- Brazil Wearable Injectors Market, By Type
- Brazil Wearable Injectors Market, By Application
- Brazil Wearable Injectors Market, By End User
- South Africa Wearable Injectors Market, By Technology
- South Africa Wearable Injectors Market, By Type
- South Africa Wearable Injectors Market, By Application
- South Africa Wearable Injectors Market, By End User
- Saudi Arabia Wearable Injectors Market, By Technology
- Saudi Arabia Wearable Injectors Market, By Type
- Saudi Arabia Wearable Injectors Market, By Application
- Saudi Arabia Wearable Injectors Market, By End User
- Turkey Wearable Injectors Market, By Technology
- Turkey Wearable Injectors Market, By Type
- Turkey Wearable Injectors Market, By Application
- Turkey Wearable Injectors Market, By End User
- United Arab Emirates Wearable Injectors Market, By Technology
- United Arab Emirates Wearable Injectors Market, By Type
- United Arab Emirates Wearable Injectors Market, By Application
- United Arab Emirates Wearable Injectors Market, By End User
- Others Wearable Injectors Market, By Technology
- Others Wearable Injectors Market, By Type
- Others Wearable Injectors Market, By Application
- Others Wearable Injectors Market, By End User
- Rest of the World
Table of Contents
1. Introduction
1.1. Report Description
1.2. Research Methodology
1.2.1. Secondary Research
1.2.2. Primary Research
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Share Analysis
3.3. Market Dynamics
3.3.1. Drivers
3.3.1.1. Increase Demand for Advanced Drug Delivery Systems
3.3.1.2. Advantages of Wearable Injectors over Traditional Drug Delivery systems
3.3.1.3. Growing Applications of Biologics
3.3.1.4. Increasing Incidence of Chronic Disorders such as Cancer
3.3.2. Restraints
3.3.2.1. Availability of Alternative Drug Delivery Products
3.3.3. Opportunities
3.3.3.1. Emerging Countries to Offer Lucrative Growth Opportunities
4. Wearable Injectors Market, By Technology
4.1. Introduction
4.2. The Wearable Injectors Market Assessment and Forecast, By Technology, 2017-2027
4.3. Mechanical Injectors
4.3.1. Market Assessment and Forecast, By Region, 2017-2027 ($Million)
4.4. Electronic Injectors
4.4.1. Market Assessment and Forecast, By Region, 2017-2027 ($Million)
4.5. Other Technologies
4.5.1. Market Assessment and Forecast, By Region, 2017-2027 ($Million)
5. Wearable Injectors Market, By Type
5.1. Introduction
5.2. The Wearable Injectors Market Assessment and Forecast, By Type 2017-2027
5.3. Off-Body Worn Belt Injectors
5.3.1. Market Assessment and Forecast, By Region, 2017-2027 ($Million)
5.4. Body-Worn Patch Injectors
5.4.1. Market Assessment and Forecast, By Region, 2017-2027 ($Million)
5.5. Other Injector Types
5.5.1. Market Assessment and Forecast, By Region, 2017-2027 ($Million)
6. Wearable Injectors Market, By Application
6.1. Introduction
6.2. Wearable Injectors Market Assessment and Forecast, By Application, 2017-2027 ($Million)
6.3. Blood Disorders
6.3.1. Market Assessment and Forecast, By Region, 2017-2027 ($Million)
6.4. Infectious Diseases
6.4.1. Market Assessment and Forecast, By Region, 2017-2027 ($Million)
6.5. Cancer
6.5.1. Market Assessment and Forecast, By Region, 2017-2027 ($Million)
6.6. Cardiovascular Diseases
6.6.1. Market Assessment and Forecast, By Region, 2017-2027 ($Million)
6.7. Autoimmune Disorders
6.7.1. Market Assessment and Forecast, By Region, 2017-2027 ($Million)
6.8. Other Applications
6.8.1. Market Assessment and Forecast, By Region, 2017-2027 ($Million)
7. Wearable Injectors Market, By End User
7.1. Introduction
7.2. Wearable Injectors Market Assessment and Forecast, By Application, 2017-2027 ($Million)
7.3. Lab and Diagnostics
7.3.1. Market Assessment and Forecast, By Region, 2017-2027 ($Million)
7.4. Hospital Care
7.4.1. Market Assessment and Forecast, By Region, 2017-2027 ($Million)
7.5. Home Care
7.5.1. Market Assessment and Forecast, By Region, 2017-2027 ($Million)
7.6. Other End Users
7.6.1. Market Assessment and Forecast, By Region, 2017-2027 ($Million)
8. Wearable Injectors Market, By Region
8.1. Introduction
8.2. Wearable Injectors Market Assessment and Forecast, By Region, 2017-2027 ($Million)
8.3. North America
8.3.1. Market Assessment and Forecast, By Country, 2017-2027 ($Million)
8.3.2. Market Assessment and Forecast, By Technology, 2017-2027 ($Million)
8.3.3. Market Assessment and Forecast, By Type, 2017-2027 ($Million)
8.3.4. Market Assessment and Forecast, By Application, 2017-2027 ($Million)
8.3.5. Market Assessment and Forecast, By End User, 2017-2027 ($Million)
8.3.5.1. U.S.
8.3.5.1.1. Market Assessment and Forecast, By Technology, 2017-2027 ($Million)
8.3.5.1.2. Market Assessment and Forecast, By Type, 2017-2027 ($Million)
8.3.5.1.3. Market Assessment and Forecast, By Application, 2017-2027 ($Million)
8.3.5.1.4. Market Assessment and Forecast, By End User, 2017-2027 ($Million)
8.3.5.2. Canada
8.3.5.2.1. Market Assessment and Forecast, By Technology, 2017-2027 ($Million)
8.3.5.2.2. Market Assessment and Forecast, By Type, 2017-2027 ($Million)
8.3.5.2.3. Market Assessment and Forecast, By Application, 2017-2027 ($Million)
8.3.5.2.4. Market Assessment and Forecast, By End User, 2017-2027 ($Million)
8.3.5.3. Mexico
8.3.5.3.1. Market Assessment and Forecast, By Technology, 2017-2027 ($Million)
8.3.5.3.2. Market Assessment and Forecast, By Type, 2017-2027 ($Million)
8.3.5.3.3. Market Assessment and Forecast, By Application, 2017-2027 ($Million)
8.3.5.3.4. Market Assessment and Forecast, By End User, 2017-2027 ($Million)
8.4. Europe
8.4.1. Market Assessment and Forecast, By Country, 2017-2027 ($Million)
8.4.2. Market Assessment and Forecast, By Technology, 2017-2027 ($Million)
8.4.3. Market Assessment and Forecast, By Type, 2017-2027 ($Million)
8.4.4. Market Assessment and Forecast, By Application, 2017-2027 ($Million)
8.4.5. Market Assessment and Forecast, By End User, 2017-2027 ($Million)
8.4.5.1. Germany
8.4.5.1.1. Market Assessment and Forecast, By Technology, 2017-2027 ($Million)
8.4.5.1.2. Market Assessment and Forecast, By Type, 2017-2027 ($Million)
8.4.5.1.3. Market Assessment and Forecast, By Application, 2017-2027 ($Million)
8.4.5.1.4. Market Assessment and Forecast, By End User, 2017-2027 ($Million)
8.4.5.2. France
8.4.5.2.1. Market Assessment and Forecast, By Technology, 2017-2027 ($Million)
8.4.5.2.2. Market Assessment and Forecast, By Type, 2017-2027 ($Million)
8.4.5.2.3. Market Assessment and Forecast, By Application, 2017-2027 ($Million)
8.4.5.2.4. Market Assessment and Forecast, By End User, 2017-2027 ($Million)
8.4.5.3. UK
8.4.5.3.1. Market Assessment and Forecast, By Technology, 2017-2027 ($Million)
8.4.5.3.2. Market Assessment and Forecast, By Type, 2017-2027 ($Million)
8.4.5.3.3. Market Assessment and Forecast, By Application, 2017-2027 ($Million)
8.4.5.3.4. Market Assessment and Forecast, By End User, 2017-2027 ($Million)
8.4.5.4. Italy
8.4.5.4.1. Market Assessment and Forecast, By Technology, 2017-2027 ($Million)
8.4.5.4.2. Market Assessment and Forecast, By Type, 2017-2027 ($Million)
8.4.5.4.3. Market Assessment and Forecast, By Application, 2017-2027 ($Million)
8.4.5.4.4. Market Assessment and Forecast, By End User, 2017-2027 ($Million)
8.4.5.5. Spain
8.4.5.5.1. Market Assessment and Forecast, By Technology, 2017-2027 ($Million)
8.4.5.5.2. Market Assessment and Forecast, By Type, 2017-2027 ($Million)
8.4.5.5.3. Market Assessment and Forecast, By Application, 2017-2027 ($Million)
8.4.5.5.4. Market Assessment and Forecast, By End User, 2017-2027 ($Million)
8.4.5.6. Russia
8.4.5.6.1. Market Assessment and Forecast, By Technology, 2017-2027 ($Million)
8.4.5.6.2. Market Assessment and Forecast, By Type, 2017-2027 ($Million)
8.4.5.6.3. Market Assessment and Forecast, By Application, 2017-2027 ($Million)
8.4.5.6.4. Market Assessment and Forecast, By End User, 2017-2027 ($Million)
8.4.5.7. Rest of Europe
8.4.5.7.1. Market Assessment and Forecast, By Technology, 2017-2027 ($Million)
8.4.5.7.2. Market Assessment and Forecast, By Type, 2017-2027 ($Million)
8.4.5.7.3. Market Assessment and Forecast, By Application, 2017-2027 ($Million)
8.4.5.7.4. Market Assessment and Forecast, By End User, 2017-2027 ($Million)
8.5. Asia-Pacific
8.5.1. Market Assessment and Forecast, By Country, 2017-2027 ($Million)
8.5.2. Market Assessment and Forecast, By Technology, 2017-2027 ($Million)
8.5.3. Market Assessment and Forecast, By Type, 2017-2027 ($Million)
8.5.4. Market Assessment and Forecast, By Application, 2017-2027 ($Million)
8.5.5. Market Assessment and Forecast, By End User, 2017-2027 ($Million)
8.5.5.1. Japan
8.5.5.1.1. Market Assessment and Forecast, By Technology, 2017-2027 ($Million)
8.5.5.1.2. Market Assessment and Forecast, By Type, 2017-2027 ($Million)
8.5.5.1.3. Market Assessment and Forecast, By Application, 2017-2027 ($Million)
8.5.5.1.4. Market Assessment and Forecast, By End User, 2017-2027 ($Million)
8.5.5.2. China
8.5.5.2.1. Market Assessment and Forecast, By Technology, 2017-2027 ($Million)
8.5.5.2.2. Market Assessment and Forecast, By Type, 2017-2027 ($Million)
8.5.5.2.3. Market Assessment and Forecast, By Application, 2017-2027 ($Million)
8.5.5.2.4. Market Assessment and Forecast, By End User, 2017-2027 ($Million)
8.5.5.3. Australia
8.5.5.3.1. Market Assessment and Forecast, By Technology, 2017-2027 ($Million)
8.5.5.3.2. Market Assessment and Forecast, By Type, 2017-2027 ($Million)
8.5.5.3.3. Market Assessment and Forecast, By Application, 2017-2027 ($Million)
8.5.5.3.4. Market Assessment and Forecast, By End User, 2017-2027 ($Million)
8.5.5.4. India
8.5.5.4.1. Market Assessment and Forecast, By Technology, 2017-2027 ($Million)
8.5.5.4.2. Market Assessment and Forecast, By Type, 2017-2027 ($Million)
8.5.5.4.3. Market Assessment and Forecast, By Application, 2017-2027 ($Million)
8.5.5.4.4. Market Assessment and Forecast, By End User, 2017-2027 ($Million)
8.5.5.5. South Korea
8.5.5.5.1. Market Assessment and Forecast, By Technology, 2017-2027 ($Million)
8.5.5.5.2. Market Assessment and Forecast, By Type, 2017-2027 ($Million)
8.5.5.5.3. Market Assessment and Forecast, By Application, 2017-2027 ($Million)
8.5.5.5.4. Market Assessment and Forecast, By End User, 2017-2027 ($Million)
8.5.5.6. Taiwan
8.5.5.6.1. Market Assessment and Forecast, By Technology, 2017-2027 ($Million)
8.5.5.6.2. Market Assessment and Forecast, By Type, 2017-2027 ($Million)
8.5.5.6.3. Market Assessment and Forecast, By Application, 2017-2027 ($Million)
8.5.5.6.4. Market Assessment and Forecast, By End User, 2017-2027 ($Million)
8.5.5.7. Rest of Asia-Pacific
8.5.5.7.1. Market Assessment and Forecast, By Technology, 2017-2027 ($Million)
8.5.5.7.2. Market Assessment and Forecast, By Type, 2017-2027 ($Million)
8.5.5.7.3. Market Assessment and Forecast, By Application, 2017-2027 ($Million)
8.5.5.7.4. Market Assessment and Forecast, By End User, 2017-2027 ($Million)
8.6. Rest of the World
8.6.1. Market Assessment and Forecast, By Country, 2017-2027 ($Million)
8.6.2. Market Assessment and Forecast, By Technology, 2017-2027 ($Million)
8.6.3. Market Assessment and Forecast, By Type, 2017-2027 ($Million)
8.6.4. Market Assessment and Forecast, By Application, 2017-2027 ($Million)
8.6.5. Market Assessment and Forecast, By End User, 2017-2027 ($Million)
8.6.5.1. Brazil
8.6.5.1.1. Market Assessment and Forecast, By Technology, 2017-2027 ($Million)
8.6.5.1.2. Market Assessment and Forecast, By Type, 2017-2027 ($Million)
8.6.5.1.3. Market Assessment and Forecast, By Application, 2017-2027 ($Million)
8.6.5.1.4. Market Assessment and Forecast, By End User, 2017-2027 ($Million)
8.6.5.2. Turkey
8.6.5.2.1. Market Assessment and Forecast, By Technology, 2017-2027 ($Million)
8.6.5.2.2. Market Assessment and Forecast, By Type, 2017-2027 ($Million)
8.6.5.2.3. Market Assessment and Forecast, By Application, 2017-2027 ($Million)
8.6.5.2.4. Market Assessment and Forecast, By End User, 2017-2027 ($Million)
8.6.5.3. Saudi Arabia
8.6.5.3.1. Market Assessment and Forecast, By Technology, 2017-2027 ($Million)
8.6.5.3.2. Market Assessment and Forecast, By Type, 2017-2027 ($Million)
8.6.5.3.3. Market Assessment and Forecast, By Application, 2017-2027 ($Million)
8.6.5.3.4. Market Assessment and Forecast, By End User, 2017-2027 ($Million)
8.6.5.4. South Africa
8.6.5.4.1. Market Assessment and Forecast, By Technology, 2017-2027 ($Million)
8.6.5.4.2. Market Assessment and Forecast, By Type, 2017-2027 ($Million)
8.6.5.4.3. Market Assessment and Forecast, By Application, 2017-2027 ($Million)
8.6.5.4.4. Market Assessment and Forecast, By End User, 2017-2027 ($Million)
8.6.5.5. United Arab Emirates
8.6.5.5.1. Market Assessment and Forecast, By Technology, 2017-2027 ($Million)
8.6.5.5.2. Market Assessment and Forecast, By Type, 2017-2027 ($Million)
8.6.5.5.3. Market Assessment and Forecast, By Application, 2017-2027 ($Million)
8.6.5.5.4. Market Assessment and Forecast, By End User, 2017-2027 ($Million)
8.6.5.6. Others
8.6.5.6.1. Market Assessment and Forecast, By Technology, 2017-2027 ($Million)
8.6.5.6.2. Market Assessment and Forecast, By Type, 2017-2027 ($Million)
8.6.5.6.3. Market Assessment and Forecast, By Application, 2017-2027 ($Million)
8.6.5.6.4. Market Assessment and Forecast, By End User, 2017-2027 ($Million)
9. Company Profiles
9.1. Amgen Inc.
9.1.1. Business Overview
9.1.2. Product Portfolio
9.1.3. Key Financials
9.1.4. Strategic Developments
9.2. Enable Injections, Inc.
9.2.1. Business Overview
9.2.2. Product Portfolio
9.2.3. Strategic Developments
9.3. Insulet Corporation
9.3.1. Business Overview
9.3.2. Product Portfolio
9.3.3. Key Financials
9.3.4. Strategic Developments
9.4. West Pharmaceutical Services, Inc.
9.4.1. Business Overview
9.4.2. Product Portfolio
9.4.3. Key Financials
9.4.4. Strategic Developments
9.5. Becton, Dickinson and Company
9.5.1. Business Overview
9.5.2. Product Portfolio
9.5.3. Key Financials
9.5.4. Strategic Developments
9.6. Ypsomed AG
9.6.1. Business Overview
9.6.2. Product Portfolio
9.6.3. Key Financials
9.6.4. Strategic Developments
9.7. Unilife Corporation
9.7.1. Business Overview
9.7.2. Product Portfolio
9.7.3. Key Financials
9.7.4. Strategic Developments
9.8. Sensile Medical AG
9.8.1. Business Overview
9.8.2. Product Portfolio
9.8.3. Strategic Developments
List of Tables
Table 1.Wearable Injectors Market, By Technology, 2017-2025 ($Million)
Table 2.Mechanical Injectors Market, By Region, 2017-2025 ($Million)
Table 3.Electronic Injectors Market, By Region, 2017-2025 ($Million)
Table 4.Other Technologies Market, By Region, 2017-2025 ($Million)
Table 5.Wearable Injectors Market, By Type, 2017-2025 ($Million)
Table 6.Off-Body Worn Belt Injectors Market, By Region, 2017-2025 ($Million)
Table 7.Body-Worn Patch Injectors Market, By Region, 2017-2025 ($Million)
Table 8.Other Injector Types Market, By Region, 2017-2025 ($Million)
Table 9.Wearable Injectors Market, By Application, 2017-2025 ($Million)
Table 10.Blood Disorders Market, By Region, 2017-2025 ($Million)
Table 11.Infectious Diseases Market, By Region, 2017-2025 ($Million)
Table 12.Cancer Market, By Region, 2017-2025 ($Million)
Table 13.Cardiovascular Diseases Market, By Region, 2017-2025 ($Million)
Table 14.Autoimmune Disorders Market, By Region, 2017-2025 ($Million)
Table 15.Other Applications Market, By Region, 2017-2025 ($Million)
Table 16.Wearable Injectors Market, By End User, 2017-2025 ($Million)
Table 17.Lab and Diagnostics Market, By Region, 2017-2025 ($Million)
Table 18.Hospital Care Market, By Region, 2017-2025 ($Million)
Table 19.Home Care Market, By Region, 2017-2025 ($Million)
Table 20.Other End Users Market, By Region, 2017-2025 ($Million)
Table 21.Wearable Injectors Market, By Region, 2017-2025 ($Million)
Table 22.North America Wearable Injectors Market, By Country, 2017-2025 ($Million)
Table 23.North America Wearable Injectors Market, By Technology, 2017-2025 ($Million)
Table 24.North America Wearable Injectors Market, By Type, 2017-2025 ($Million)
Table 25.North America Wearable Injectors Market, By Application, 2017-2025 ($Million)
Table 26.North America Wearable Injectors Market, By End User, 2017-2025 ($Million)
Table 27.U.S. Wearable Injectors Market, By Technology, 2017-2025 ($Million)
Table 28.U.S. Wearable Injectors Market, By Type, 2017-2025 ($Million)
Table 29.U.S. Wearable Injectors Market, By Application, 2017-2025 ($Million)
Table 30.U.S. Wearable Injectors Market, By End User, 2017-2025 ($Million)
Table 31.Canada Wearable Injectors Market, By Technology, 2017-2025 ($Million)
Table 32.Canada Wearable Injectors Market, By Type, 2017-2025 ($Million)
Table 33.Canada Wearable Injectors Market, By Application, 2017-2025 ($Million)
Table 34.Canada Wearable Injectors Market, By End User, 2017-2025 ($Million)
Table 35.Mexico Wearable Injectors Market, By Technology, 2017-2025 ($Million)
Table 36.Mexico Wearable Injectors Market, By Type, 2017-2025 ($Million)
Table 37.Mexico Wearable Injectors Market, By Application, 2017-2025 ($Million)
Table 38.Mexico Wearable Injectors Market, By End User, 2017-2025 ($Million)
Table 39.Europe Wearable Injectors Market, By Country, 2017-2025 ($Million)
Table 40.Europe Wearable Injectors Market, By Technology, 2017-2025 ($Million)
Table 41.Europe Wearable Injectors Market, By Type, 2017-2025 ($Million)
Table 42.Europe Wearable Injectors Market, By Application, 2017-2025 ($Million)
Table 43.Europe Wearable Injectors Market, By End User, 2017-2025 ($Million)
Table 44.Germany Wearable Injectors Market, By Technology, 2017-2025 ($Million)
Table 45.Germany Wearable Injectors Market, By Type, 2017-2025 ($Million)
Table 46.Germany Wearable Injectors Market, By Application, 2017-2025 ($Million)
Table 47.Germany Wearable Injectors Market, By End User, 2017-2025 ($Million)
Table 48.France Wearable Injectors Market, By Technology, 2017-2025 ($Million)
Table 49.France Wearable Injectors Market, By Type, 2017-2025 ($Million)
Table 50.France Wearable Injectors Market, By Application, 2017-2025 ($Million)
Table 51.France Wearable Injectors Market, By End User, 2017-2025 ($Million)
Table 52.UK Wearable Injectors Market, By Technology, 2017-2025 ($Million)
Table 53.UK Wearable Injectors Market, By Type, 2017-2025 ($Million)
Table 54.UK Wearable Injectors Market, By Application, 2017-2025 ($Million)
Table 55.UK Wearable Injectors Market, By End User, 2017-2025 ($Million)
Table 56.Italy Wearable Injectors Market, By Technology, 2017-2025 ($Million)
Table 57.Italy Wearable Injectors Market, By Type, 2017-2025 ($Million)
Table 58.Italy Wearable Injectors Market, By Application, 2017-2025 ($Million)
Table 59.Italy Wearable Injectors Market, By End User, 2017-2025 ($Million)
Table 60.Spain Wearable Injectors Market, By Technology, 2017-2025 ($Million)
Table 61.Spain Wearable Injectors Market, By Type, 2017-2025 ($Million)
Table 62.Spain Wearable Injectors Market, By Application, 2017-2025 ($Million)
Table 63.Spain Wearable Injectors Market, By End User, 2017-2025 ($Million)
Table 64.Russia Wearable Injectors Market, By Technology, 2017-2025 ($Million)
Table 65.Russia Wearable Injectors Market, By Type, 2017-2025 ($Million)
Table 66.Russia Wearable Injectors Market, By Application, 2017-2025 ($Million)
Table 67.Russia Wearable Injectors Market, By End User, 2017-2025 ($Million)
Table 68.Rest of Europe Wearable Injectors Market, By Technology, 2017-2025 ($Million)
Table 69.Rest of Europe Wearable Injectors Market, By Type, 2017-2025 ($Million)
Table 70.Rest of Europe Wearable Injectors Market, By Application, 2017-2025 ($Million)
Table 71.Rest of Europe Wearable Injectors Market, By End User, 2017-2025 ($Million)
Table 72.Asia-Pacific Wearable Injectors Market, By Country, 2017-2025 ($Million)
Table 73.Asia-Pacific Wearable Injectors Market, By Technology, 2017-2025 ($Million)
Table 74.Asia-Pacific Wearable Injectors Market, By Type, 2017-2025 ($Million)
Table 75.Asia-Pacific Wearable Injectors Market, By Application, 2017-2025 ($Million)
Table 76.Asia-Pacific Wearable Injectors Market, By End User, 2017-2025 ($Million)
Table 77.Japan Wearable Injectors Market, By Technology, 2017-2025 ($Million)
Table 78.Japan Wearable Injectors Market, By Type, 2017-2025 ($Million)
Table 79.Japan Wearable Injectors Market, By Application, 2017-2025 ($Million)
Table 80.Japan Wearable Injectors Market, By End User, 2017-2025 ($Million)
Table 81.China Wearable Injectors Market, By Technology, 2017-2025 ($Million)
Table 82.China Wearable Injectors Market, By Type, 2017-2025 ($Million)
Table 83.China Wearable Injectors Market, By Application, 2017-2025 ($Million)
Table 84.China Wearable Injectors Market, By End User, 2017-2025 ($Million)
Table 85.Australia Wearable Injectors Market, By Technology, 2017-2025 ($Million)
Table 86.Australia Wearable Injectors Market, By Type, 2017-2025 ($Million)
Table 87.Australia Wearable Injectors Market, By Application, 2017-2025 ($Million)
Table 88.Australia Wearable Injectors Market, By End User, 2017-2025 ($Million)
Table 89.India Wearable Injectors Market, By Technology, 2017-2025 ($Million)
Table 90.India Wearable Injectors Market, By Type, 2017-2025 ($Million)
Table 91.India Wearable Injectors Market, By Application, 2017-2025 ($Million)
Table 92.India Wearable Injectors Market, By End User, 2017-2025 ($Million)
Table 93.South Korea Wearable Injectors Market, By Technology, 2017-2025 ($Million)
Table 94.South Korea Wearable Injectors Market, By Type, 2017-2025 ($Million)
Table 95.South Korea Wearable Injectors Market, By Application, 2017-2025 ($Million)
Table 96.South Korea Wearable Injectors Market, By End User, 2017-2025 ($Million)
Table 97.Rest of Asia-Pacific Wearable Injectors Market, By Technology, 2017-2025 ($Million)
Table 98.Rest of Asia-Pacific Wearable Injectors Market, By Type, 2017-2025 ($Million)
Table 99.Rest of Asia-Pacific Wearable Injectors Market, By Application, 2017-2025 ($Million)
Table 100.Rest of Asia-Pacific Wearable Injectors Market, By End User, 2017-2025 ($Million)
Table 101.Rest of the World Wearable Injectors Market, By Country, 2017-2025 ($Million)
Table 102.Rest of the World Wearable Injectors Market, By Technology, 2017-2025 ($Million)
Table 103.Rest of the World Wearable Injectors Market, By Type, 2017-2025 ($Million)
Table 104.Rest of the World Wearable Injectors Market, By Application, 2017-2025 ($Million)
Table 105.Rest of the World Wearable Injectors Market, By End User, 2017-2025 ($Million)
Table 106.Brazil Wearable Injectors Market, By Technology, 2017-2025 ($Million)
Table 107.Brazil Wearable Injectors Market, By Type, 2017-2025 ($Million)
Table 108.Brazil Wearable Injectors Market, By Application, 2017-2025 ($Million)
Table 109.Brazil Wearable Injectors Market, By End User, 2017-2025 ($Million)
Table 110.Turkey Wearable Injectors Market, By Technology, 2017-2025 ($Million)
Table 111.Turkey Wearable Injectors Market, By Type, 2017-2025 ($Million)
Table 112.Turkey Wearable Injectors Market, By Application, 2017-2025 ($Million)
Table 113.Turkey Wearable Injectors Market, By End User, 2017-2025 ($Million)
Table 114.Saudi Arabia Wearable Injectors Market, By Technology, 2017-2025 ($Million)
Table 115.Saudi Arabia Wearable Injectors Market, By Type, 2017-2025 ($Million)
Table 116.Saudi Arabia Wearable Injectors Market, By Application, 2017-2025 ($Million)
Table 117.Saudi Arabia Wearable Injectors Market, By End User, 2017-2025 ($Million)
Table 118.South Africa Wearable Injectors Market, By Technology, 2017-2025 ($Million)
Table 119.South Africa Wearable Injectors Market, By Type, 2017-2025 ($Million)
Table 120.South Africa Wearable Injectors Market, By Application, 2017-2025 ($Million)
Table 121.South Africa Wearable Injectors Market, By End User, 2017-2025 ($Million)
Table 122.United Arab Emirates Wearable Injectors Market, By Technology, 2017-2025 ($Million)
Table 123.United Arab Emirates Wearable Injectors Market, By Type, 2017-2025 ($Million)
Table 124.United Arab Emirates Wearable Injectors Market, By Application, 2017-2025 ($Million)
Table 125.United Arab Emirates Wearable Injectors Market, By End User, 2017-2025 ($Million)
Table 126.Others Wearable Injectors Market, By Technology, 2017-2025 ($Million)
Table 127.Others Wearable Injectors Market, By Type, 2017-2025 ($Million)
Table 128.Others Wearable Injectors Market, By Application, 2017-2025 ($Million)
Table 129.Others Wearable Injectors Market, By End User, 2017-2025 ($Million)
Table 130.Amgen Inc.: Key Strategic Developments, 2017-2017
Table 131.Enable Injections, Inc.: Key Strategic Developments, 2017-2017
Table 132.Insulet Corporation: Key Strategic Developments, 2017-2017
Table 133.West Pharmaceutical Services, Inc.: Key Strategic Developments, 2017-2017
Table 134.Becton, Dickinson and Company: Key Strategic Developments, 2017-2017
Table 135.Ypsomed AG: Key Strategic Developments, 2017-2017
Table 136.Unilife Corporation: Key Strategic Developments, 2017-2017
Table 137.Sensile Medical AG: Key Strategic Developments, 2017-2017
List of Figures
Figure 1.Wearable Injectors Market Share, By Technology, 2017 & 2025 ($Million)
Figure 2.Wearable Injectors Market Share, By Type, 2017 & 2025 ($Million)
Figure 3.Wearable Injectors Market Share, By Application, 2017 & 2025 ($Million)
Figure 4.Wearable Injectors Market Share, By End User, 2017 & 2025 ($Million)
Figure 5.Wearable Injectors Market, By Region, 2017, ($Million)
Figure 6.Amgen Inc.: Net Revenues, 2017-2017 ($Million)
Figure 7.Amgen Inc.: Net Revenue Share, By Segment, 2017
Figure 8.Amgen Inc.: Net Revenue Share, By Geography, 2017
Figure 9.Insulet Corporation: Net Revenues, 2017-2017 ($Million)
Figure 10.Insulet Corporation: Net Revenue Share, By Segment, 2017
Figure 11.Insulet Corporation: Net Revenue Share, By Geography, 2017
Figure 12.West Pharmaceutical Services, Inc.: Net Revenues, 2017-2017 ($Million)
Figure 13.West Pharmaceutical Services, Inc.: Net Revenue Share, By Segment, 2017
Figure 14.West Pharmaceutical Services, Inc.: Net Revenue Share, By Geography, 2017
Figure 15.Becton, Dickinson and Company: Net Revenues, 2017-2017 ($Million)
Figure 16.Becton, Dickinson and Company: Net Revenue Share, By Segment, 2017
Figure 17.Becton, Dickinson and Company: Net Revenue Share, By Geography, 2017
Figure 18.Ypsomed AG: Net Revenues, 2017-2017 ($Million)
Figure 19.Ypsomed AG: Net Revenue Share, By Segment, 2017
Figure 20.Ypsomed AG: Net Revenue Share, By Geography, 2017
Figure 21.Unilife Corporation: Net Revenues, 2017-2017 ($Million)
Figure 22. Unilife Corporation: Net Revenue Share, By Segment, 2017
Figure 23.Unilife Corporation: Net Revenue Share, By Geography, 2017
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|